ARCHIVES

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

This article is from The Cancer Letter archive.

Vol. 40 No. 39 | October 17, 2014

Download PDF Visit The Full Archive

Related Articles

HEW To Pay All Care Cost At 26 Hospices

January 11, 1980

Carbone to Give Up ECOG Chairmanship; DCE’s Adamson Receives Presidential Executive Award

October 6, 1989

Study Sheds Light On How NSAIDS Prevent Colon Cancer

April 25, 2003

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011

Scientific, Funding Challenges Test NCI Prevention Effort, Broder Says In First Speech to DCPC Board

February 3, 1989

Ethics rules slammed by NIH scientists, institute directors, societies, Senators.

April 8, 2005